Harold H. Shlevin
CIK 1557082 · Chief Executive Officer · last filed 2026-01-21
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$17.4K
Companies
2
Total Filings
28
Lifetime Open-Market Net
-$3.67M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| GALT | Director | 6,500 | $2.67 | $17.4K | -$3.68M | 20 | 2026-01-21 |
| GALECTIN THERAPEUTICS INC (GALTW) Delisted | Chief Operating Officer | 103,914 | — | — | $3.3K | 8 | 2016-12-06 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-06-05 | GALT | Exer (M) | +8,706 | $11.9K | EDGAR |
| 2019-01-18 | GALT | Grant (A) | — | $0 | EDGAR |
| 2018-06-18 | GALT | Grant (A) | — | $0 | EDGAR |
| 2018-06-14 | GALT | Mixed | −18,154 | -$324.0K | EDGAR |
| 2018-06-12 | GALT | Mixed | −35,760 | -$588.4K | EDGAR |
| 2018-06-08 | GALT | Mixed | — | -$361.3K | EDGAR |
| 2018-06-06 | GALT | Mixed | — | -$73.1K | EDGAR |
| 2018-06-04 | GALT | Mixed | — | -$412.9K | EDGAR |
| 2018-05-24 | GALT | Grant (A) | — | $0 | EDGAR |
| 2018-01-17 | GALT | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.